The life cycle of Dermacentor variabilis and Dermacentor andersoni ticks (Family Ixodidae)Petechial rash caused by rocky mountain spotted fever on the arm
Find information on thousands of medical conditions and prescription drugs.

Rocky Mountain spotted fever

Rocky Mountain spotted fever is the most severe and most frequently reported rickettsial illness in the United States, and has been diagnosed throughout the Americas. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
Gastroesophageal reflux...
Rabies
Radiophobia
Rasmussen's encephalitis
Raynaud's phenomenon
Reactive arthritis
Reactive hypoglycemia
Reflex sympathetic...
Regional enteritis
Reiter's Syndrome
Renal agenesis
Renal artery stenosis
Renal calculi
Renal cell carcinoma
Renal cell carcinoma
Renal cell carcinoma
Renal failure
Renal osteodystrophy
Renal tubular acidosis
Repetitive strain injury
Respiratory acidosis
Restless legs syndrome
Retinitis pigmentosa
Retinoblastoma
Retinoschisis
Retrolental fibroplasia
Retroperitoneal fibrosis
Rett syndrome
Reye's syndrome
Rh disease
Rhabdomyolysis
Rhabdomyosarcoma
Rheumatic fever
Rheumatism
Rheumatoid arthritis
Rickets
Rift Valley fever
Ringworm
Rocky Mountain spotted fever
Romano-Ward syndrome
Roseola infantum
Rubella
Rubeola
Rubinstein-Taybi syndrome
Rumination disorder
S
T
U
V
W
X
Y
Z
Medicines

Some synonyms for Rocky Mountain spotted fever in other countries include "tick typhus", "Tobia fever" (Columbia), "São Paulo fever" and "febre maculosa" (Brazil), and "fiebre manchada" (Mexico). The disease is caused by Rickettsia rickettsii, a species of bacteria that is spread to humans by hard ticks (Ixodidae). Initial signs and symptoms of the disease include sudden onset of fever, headache, and muscle pain, followed by development of rash. The disease can be difficult to diagnose in the early stages, and without prompt and appropriate treatment it can be fatal.

Rocky Mountain spotted fever was first recognized in 1896 in the Snake River Valley of Idaho and was originally called "black measles" because of the characteristic rash. It was a dreaded and frequently fatal disease that affected hundreds of people in this area. By the early 1900s, the recognized geographic distribution of this disease grew to encompass parts of the United States as far north as Washington and Montana and as far south as California, Arizona, and New Mexico.

Howard T. Ricketts was the first to establish the identity of the infectious organism that causes this disease. He and others characterized the basic epidemiological features of the disease, including the role of tick vectors. Their studies found that Rocky Mountain spotted fever is caused by Rickettsia rickettsii. This species is maintained in nature by a complex cycle involving ticks and mammals; humans are considered to be accidental hosts and are not involved in the natural transmission cycle of this pathogen. Tragically, Dr. Ricketts died of typhus (another rickettsial disease) in Mexico in 1910, shortly after completing his remarkable studies on Rocky Mountain spotted fever.

The name Rocky Mountain spotted fever is somewhat of a misnomer. Beginning in the 1930s, it became clear that this disease occurred in many areas of the United States other than the Rocky Mountain region. It is now recognized that this disease is broadly distributed throughout the continental United States, as well as southern Canada, Central America, Mexico, and parts of South America. Between 1981 and 1996, this disease was reported from every U.S. state except Hawaii, Vermont, Maine, and Alaska.

Rocky Mountain spotted fever remains a serious and potentially life-threatening infectious disease today. Despite the availability of effective treatment and advances in medical care, approximately 3% to 5% of individuals who become ill with Rocky Mountain spotted fever still die from the infection. However, effective antibiotic therapy has dramatically reduced the number of deaths caused by Rocky Mountain spotted fever; before the discovery of tetracycline and chloramphenicol in the late 1940s, as many as 30% of persons infected with R. rickettsii died.

Read more at Wikipedia.org


[List your site here Free!]


Rocky Mountain spotted fever - United States, 1990
From Morbidity and Mortality Weekly Report, 7/12/91

In 1990, state health departments reported 649 cases of Rocky Mountain spotted fever (RMSF) to CDC, a 7.6% increase from the 603 cases reported in 1989. The incidence rate was 0.26 per 100,000 persons. Of the 649 cases, 292 (45.0%) and 101 (15.6%) were reported from the South Atlantic and the West South Central regions, respectively. Rates were highest in North Carolina (178 cases, 2.7 per 100,000 population), Oklahoma (70 cases, 2.2 per 100,000), Tennessee (58 cases, 1.2 per 100,000), and South Carolina (43 cases, 1.2 per 100,000) (Figure 1).

Detailed case reports were submitted on 531 (81.8%) cases. Of these, 286 (53.9%) were laboratory-confirmed*, 12 (2.3%) were classified as probable', and 233 (43.9%) were not confirmed. Of patients with confirmed cases, 59.6% were male; 78.2% reported that onset of symptoms occurred during May 1-August 31 (44.1% of cases occurred in May or June); and 54.2% reported a tick bite within 14 days of symptom onset. Clinical manifestations included fever (88.2% of cases), headache (85.0%), myalgia (85.0%), rash 73.9%), and rash on palms (49.0%). The triad of fever, headache, and rash was present in 44.6% of the cases.

In 1990, age-specific incidence rates for laboratory-confirmed cases were highest for persons aged 5-9 years (0.21 per 100,000) and lowest for persons aged 20-29 years (0.07 per 100,000). The overall case-fatality rate for persons with laboratory-confirmed cases was 5.2%. For persons aged [greater than or equal to] 20 years, the case-fatality rate was 6.8%, and for persons aged [less than] 20 years, 2.4%.

Surveillance data from 1981 through 1990 also indicate that RMSF was most common among children 5-9 years of age and least common among persons aged 20-29 years (Figure 2). During this 10-year period, the case-fatality rate was highest for persons aged [greater than or equal to] 40 years (Figure 3); for this age group, the average case-fatality rate was 8.2%, compared with 2.3% for persons aged [less than] 40 years. The case-fatality rate was also higher (6.2%) for persons whose treatment began more than 3 days after onset of symptoms than for those treated within the first 3 days of illness (1.3%). Reported by: Viral and Rickettsial Zoonoses Br, Div of Viral and Rickettsial Diseases, National Center for Infectious Diseases, CDC.

Editorial Note: Following a sharp increase in the number of reported cases of RMSF in the early 1980s, the number and rate of cases has remained stable since 1985, with the annual incidence varying from 0.24 to 0.32 per 100,000 population. However, cases in the South Atlantic region appear to have increased after declining to a low of 200 reported cases in 1988 (224 cases reported in 1989, and 292 in 1990). For the first time since 1982, North Carolina had both the highest number of cases and the highest incidence rate. Two of the three other states with high incidence rates-Tennessee and South Carolina-border on North Carolina, suggesting a possible resurgence of cases in this area.

Persons who reside and/or work in tick-infested areas should be informed about tickborne diseases and their prevention. The optimal method for preventing RMSF is avoidance of tick-infested areas. Persons who must enter these areas should wear protective clothing and use tick repellent. In addition, exposed areas of the body should be examined every few hours for tick attachment. Ticks should be removed by grasping them with fine tweezers at the point of attachment and pulling slowly and steadily. The bite should be cleansed as any skin wound, especially if tick mouth parts remain. Ticks can be removed by hand, but care should be taken to avoid direct contact with the tick; fingers should be protected with tissue paper and washed afterwards.

The incubation period for RMSF is 3-12 days following tick bite. Although only a small proportion of persons bitten by ticks will develop RMSF or other tickborne diseases, RMSF should be considered and medical treatment sought by any potentially exposed person who develops fever, myalgia, or headache, even in the absence of a rash. Prompt treatment is particularly important for older persons, for whom the case-fatality rate is higher ( 1 ). If RMSF is suspected, treatment with tetracycline or chloramphenicol should be promptly instituted. Reference 1. D'Angelo LJ, Bregman DJ, Winkler WG. Rocky Mountain spotted fever in the United States: use of age-specific incidence to determine public health policy for a vector-borne disease. Southern Med J 1982;75:3-6.

*A case is considered serologically confirmed if testing reveals an indirect fluorescent antibody (IFA) titer of [greater than or equal to] 1:64, a complement-fixation (CF) titer of [greater than or equal to] 1:16, fourfold rise in titer by the CF, IFA, microagglutination (MA), latex agglutination (LA), or indirect hemagglutination (IHA) tests.

+A case is considered probable if testing reveals a fourfold rise in titer or a single titer -l :320 in the Weil-Felix test (OX-19 or OX-2) or an IHA, LA, or MA single titer of [greater than or equal to] 1:128.

COPYRIGHT 1991 U.S. Government Printing Office
COPYRIGHT 2004 Gale Group

Return to Rocky Mountain spotted fever
Home Contact Resources Exchange Links ebay